Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
False Claims Act
DOJ Has Third Highest Annual Recovery in FCA History
The United States Department of Justice has announced the fiscal year 2016 recoveries from civil False Claims Act. This…
Department of Justice Increases FCA Civil Penalties, Again
On February 3, 2017, the Department of Justice (DOJ) announced that False Claims Act (FCA) penalties will once again be…
Acclarent Executive Convicted of Misdemeanors and Acquitted of Felonies
The former Chief Executive Officer and Vice President of Sales of Acclarent, Inc., a medical device company and division of…
Cardiovascular Systems Inc. False Claims Act and Anti Kickback Settlement
Cardiovascular Systems, Inc. (CSI) has agreed to pay $8 million and sign a corporate integrity agreement (CIA) to settle a False…
Detecting the “Sham” in Speaker Programs
In late March 2016, Novartis Pharmaceuticals Corp. (NPC) and the U.S. Department of Justice and the State of New York…
Salix Settlement Approved
On Thursday, June 9, 2016, United States District Court Judge Denise L. Cote approved a settlement stipulation to…
DOJ Announces Genentech and OSI Pharmaceuticals, LLC Settlement
The Department of Justice (DOJ) has announced that pharmaceutical companies Genentech and OSI Pharmaceuticals, LLC, will…
House Energy and Commerce Ask FDA for Update on Off Label Guidance
The House of Representatives, through the Energy and Commerce Committee, are questioning the United States Food and Drug…
Breathing Life into Privilege, and the False Claims Act
Recent legal cases have highlighted the important issue of whether or not attorney-client privilege attaches to internal…
Peeling Back the Olympus Onion – The Importance of Culture
This article examines an apparent breakdown in corporate culture that goes beyond the subsidiaries to the parent…